Clinical Trials Browser

Phase 2 × Stomach Neoplasms × irofulven × Clear all

NCT00062257 2013-05-15

Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms